Current use of mTOR inhibitors for the treatment of subependymal giant cell astrocytomas and epilepsy in patients with TSC

Jančić, J. (Jasna), Durić, V. (Vesna), Ivančević, N. (Nikola), Nikolić, B. (Blažo), J.N. van den Anker (John) and J. Samardzic (Janko)

2016-11-01

Current Medicinal Chemistry , Volume 23 - Issue 37 p. 4260- 4269

no subscription; no PDF

Additional Metadata
Keywords	Epilepsy, mTOR inhibitors, Safety, SEGA, TSC
Persistent URL	doi.org/10.2174/0929867323666161013091144, hdl.handle.net/1765/95071
Journal	Current Medicinal Chemistry
Organisation	Department of Pediatric Surgery
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Jančić, J. (Jasna), Durić, V. (Vesna), Ivančević, N. (Nikola), Nikolić, B. (Blažo), van den Anker, J., & Samardzic, J. (2016). Current use of mTOR inhibitors for the treatment of subependymal giant cell astrocytomas and epilepsy in patients with TSC. Current Medicinal Chemistry, 23(37), 4260–4269. doi:10.2174/0929867323666161013091144

Publication